DMRA

Damora Therapeutics, Inc. Common Stock
DMRA

9 hedge funds and large institutions have $451K invested in Damora Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.52K
2
+$6K
3
+$6

Top Sellers

1
-$40.3K
2
-$2.37K
3
-$1.9K
4
BlackRock
BlackRock
New York
-$1.15K
5
Barclays
Barclays
United Kingdom
-$98
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$341K
2
$49.6K
3
$45.2K
4
$7.89K
5
$4.19K
6
$3.21K
7
$341
8
$341
9
$61
10
–
11
–